Tianyin Pharmaceutical Co., Inc. to Host Second Fiscal Quarter 2010 Results Earnings Conference Call on Monday, February 8, 2010
February 02 2010 - 8:00AM
PR Newswire (US)
CHENGDU, China, Feb. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin
Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and
supplier of modernized traditional Chinese medicine ("TCM") and
Western Pharmaceuticals based in Chengdu, China, today announced
that management will host a conference call to discuss its fiscal
2010 second quarter results at 4:30 p.m. ET on Monday, February 8,
2010. Financial results will also be released that day. Interested
parties may access the call by dialing +1-877-941-8418 from within
the United States, or +1-480-629-9809 if calling internationally.
The conference ID is 4207607. It is advisable to dial in
approximately 5-10 minutes prior to the start of the call. A replay
will be available through February 22, 2010 and can be accessed by
dialing +1-800-406-7325 (U.S.), +1-303-590-3030 (Int'l), passcode
4207607. This call is being web cast by ViaVid Broadcasting and can
be accessed at ViaVid's website at the following link:
http://viavid.net/dce.aspx?sid=00007061 . To access the web cast,
you will need to have the Windows Media Player on your desktop. For
the free download of the Media Player please visit:
http://www.microsoft.com/windows/windowsmedia/en/download/default.asp
. About Tianyin Pharmaceuticals Tianyin is a manufacturer and
supplier of modernized Traditional Chinese Medicine ("TCM") in
China. It was established in 1994 and acquired by the current
management team in August 2003. Tianyin currently has 48 SFDA
approved products, 41 which are manufactured and marketed. 22 of
these products are listed in the highly selective National Medicine
Catalog of the National Medical Insurance program. Tianyin owns and
operates two GMP manufacturing facilities and an R&D platform
supported by leading Chinese academic institutions. The Company has
also maintains a pipeline of 17 pharmaceutical products pending
approval. Tianyin has an extensive nationwide distribution network
throughout China with a sales force of 730 salespeople. The Company
is headquartered in Chengdu, Sichuan Province with two
manufacturing facilities and a total of 1,365 employees. For more
information about Tianyin, please visit
http://www.tianyinpharma.com/ . Safe Harbor Statement The
Statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks
and uncertainties including but not limited to risks associated
with the uncertainty of future financial results, additional
financing requirements, development of new products, government
approval processes, the impact of competitive products or pricing,
technological changes, the effect of economic conditions and other
uncertainties detailed in the Company's filings with the Securities
and Exchange Commission. For more information, please contact: For
the Company: Allen Tang, Ph.D., MBA, Assistant to the CEO China
Tel: +86-158-2122-5642 Email: Investors: Mr. Matthew Hayden, HC
International Tel: +1-561-245-5155 Email: DATASOURCE: Tianyin
Pharmaceutical Co., Inc. CONTACT: Allen Tang, Ph.D., MBA, Assistant
to the CEO China of Tianyin Pharmaceutical Co., Inc.,
+86-158-2122-5642, ; or Investors, Matthew Hayden of HC
International, +1-561-245-5155, Web site:
http://www.tianyinpharma.com/
http://viavid.net/dce.aspx?sid=00007061
Copyright